These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2054354)

  • 1. Synthesis of truncated amino-terminal trimers of thrombospondin.
    Sottile J; Selegue J; Mosher DF
    Biochemistry; 1991 Jul; 30(26):6556-62. PubMed ID: 2054354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and analysis of COOH-terminal deletions of the human thrombospondin molecule.
    Prochownik EV; O'Rourke K; Dixit VM
    J Cell Biol; 1989 Aug; 109(2):843-52. PubMed ID: 2760115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and initial characterization of a recombinant human thrombospondin heparin binding domain.
    Yabkowitz R; Lowe JB; Dixit VM
    J Biol Chem; 1989 Jun; 264(18):10888-96. PubMed ID: 2659597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Free thiols of platelet thrombospondin. Evidence for disulfide isomerization.
    Speziale MV; Detwiler TC
    J Biol Chem; 1990 Oct; 265(29):17859-67. PubMed ID: 2211666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombospondin 1 and thrombospondin 2 are expressed as both homo- and heterotrimers.
    O'Rourke KM; Laherty CD; Dixit VM
    J Biol Chem; 1992 Dec; 267(35):24921-4. PubMed ID: 1459996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human platelet glycoprotein IIIb binds to thrombospondin fragments bearing the C-terminal region, and/or the type I repeats (CSVTCG motif), but not to the N-terminal heparin-binding region.
    Catimel B; Leung L; el Ghissasi H; Mercier N; McGregor J
    Biochem J; 1992 May; 284 ( Pt 1)(Pt 1):231-6. PubMed ID: 1376110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of CD36 binding domains: ligand specificity controlled by dephosphorylation of an ectodomain.
    Asch AS; Liu I; Briccetti FM; Barnwell JW; Kwakye-Berko F; Dokun A; Goldberger J; Pernambuco M
    Science; 1993 Nov; 262(5138):1436-40. PubMed ID: 7504322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombospondin as a mediator of cancer cell adhesion in metastasis.
    Walz DA
    Cancer Metastasis Rev; 1992 Nov; 11(3-4):313-24. PubMed ID: 1384998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombospondin is a substrate for blood coagulation factor XIIIa.
    Bale MD; Mosher DF
    Biochemistry; 1986 Sep; 25(19):5667-73. PubMed ID: 2877688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thiol-disulfide exchange by thrombospondin: evidence for a thiol and a disulfide bond protected by calcium.
    Turk JL; Detwiler TC
    Arch Biochem Biophys; 1986 Mar; 245(2):446-54. PubMed ID: 3954362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disulfides modulate RGD-inhibitable cell adhesive activity of thrombospondin.
    Sun X; Skorstengaard K; Mosher DF
    J Cell Biol; 1992 Aug; 118(3):693-701. PubMed ID: 1379247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single chain 19-kDa fragment from bovine thrombospondin binds to type V collagen and heparin.
    Takagi J; Fujisawa T; Usui T; Aoyama T; Saito Y
    J Biol Chem; 1993 Jul; 268(21):15544-9. PubMed ID: 8340381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping of epitopes for monoclonal antibodies against human platelet thrombospondin with electron microscopy and high sensitivity amino acid sequencing.
    Galvin NJ; Dixit VM; O'Rourke KM; Santoro SA; Grant GA; Frazier WA
    J Cell Biol; 1985 Oct; 101(4):1434-41. PubMed ID: 2413043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a cDNA encoding the heparin and collagen binding domains of human thrombospondin.
    Dixit VM; Hennessy SW; Grant GA; Rotwein P; Frazier WA
    Proc Natl Acad Sci U S A; 1986 Aug; 83(15):5449-53. PubMed ID: 3461443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-type specific adhesive interactions of skeletal myoblasts with thrombospondin-1.
    Adams JC; Lawler J
    Mol Biol Cell; 1994 Apr; 5(4):423-37. PubMed ID: 7519904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topological analysis of the hepatitis B virus core particle by cysteine-cysteine cross-linking.
    Nassal M; Rieger A; Steinau O
    J Mol Biol; 1992 Jun; 225(4):1013-25. PubMed ID: 1613786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and mutagenesis of thrombospondin.
    Lawler J; Ferro P; Duquette M
    Biochemistry; 1992 Feb; 31(4):1173-80. PubMed ID: 1734965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the half-cystine residues in porcine submaxillary mucin critical for multimerization through the D-domains. Roles of the CGLCG motif in the D1- and D3-domains.
    Perez-Vilar J; Hill RL
    J Biol Chem; 1998 Dec; 273(51):34527-34. PubMed ID: 9852122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disulfide connectivity of recombinant C-terminal region of human thrombospondin 2.
    Misenheimer TM; Hahr AJ; Harms AC; Annis DS; Mosher DF
    J Biol Chem; 2001 Dec; 276(49):45882-7. PubMed ID: 11590138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the platelet agglutinating activity of thrombospondin.
    Haverstick DM; Dixit VM; Grant GA; Frazier WA; Santoro SA
    Biochemistry; 1985 Jun; 24(13):3128-34. PubMed ID: 4027236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.